[{"address1": "11682 El Camino Real", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 771 9307", "website": "https://ars-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 162, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL", "age": 58, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 3332915, "exercisedValue": 0, "unexercisedValue": 3757481}, {"maxAge": 1, "name": "Dr. Sarina  Tanimoto M.B.A., M.D.", "age": 55, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 2936973, "exercisedValue": 0, "unexercisedValue": 520353}, {"maxAge": 1, "name": "Mr. Brian T. Dorsey M.S.", "age": 55, "title": "Chief Operating Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 706970, "exercisedValue": 0, "unexercisedValue": 4750777}, {"maxAge": 1, "name": "Dr. Robert  Bell Ph.D.", "title": "Co-Founder & Chief Science Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen D. Scott CPA", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander A. Fitzpatrick Esq.", "age": 57, "title": "Chief Legal Officer & Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 677145, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Relovsky", "title": "Senior Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Chakma", "age": 34, "title": "Chief Business Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harris  Kaplan M.B.A.", "age": 72, "title": "Executive Vice President of Commercial Strategy", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Karas", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 618614, "exercisedValue": 0, "unexercisedValue": 4320554}], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.47, "open": 14.4, "dayLow": 14.26, "dayHigh": 14.9146, "regularMarketPreviousClose": 14.47, "regularMarketOpen": 14.4, "regularMarketDayLow": 14.26, "regularMarketDayHigh": 14.9146, "payoutRatio": 0.0, "beta": 0.962, "forwardPE": -19.118422, "volume": 2889957, "regularMarketVolume": 2889957, "averageVolume": 1479037, "averageVolume10days": 1962460, "averageDailyVolume10Day": 1962460, "bid": 10.65, "ask": 18.29, "bidSize": 2, "askSize": 2, "marketCap": 1435946112, "fiftyTwoWeekLow": 10.0, "fiftyTwoWeekHigh": 18.9, "priceToSalesTrailing12Months": 12.782258, "fiftyDayAverage": 16.7624, "twoHundredDayAverage": 13.99165, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1269436672, "profitMargins": -0.42743, "floatShares": 54998833, "sharesOutstanding": 98826304, "sharesShort": 15339705, "sharesShortPriorMonth": 15789752, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.15619999, "heldPercentInsiders": 0.1683, "heldPercentInstitutions": 0.85910004, "shortRatio": 11.21, "shortPercentOfFloat": 0.2555, "impliedSharesOutstanding": 98826304, "bookValue": 1.949, "priceToBook": 7.455105, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -48017000, "trailingEps": -0.48, "forwardEps": -0.76, "enterpriseToRevenue": 11.3, "enterpriseToEbitda": -21.614, "52WeekChange": 0.020365119, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 14.53, "targetHighPrice": 40.0, "targetLowPrice": 25.0, "targetMeanPrice": 31.0, "targetMedianPrice": 30.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 240130000, "totalCashPerShare": 2.43, "ebitda": -58733000, "totalDebt": 73620000, "quickRatio": 5.838, "currentRatio": 6.172, "totalRevenue": 112339000, "debtToEquity": 38.28, "revenuePerShare": 1.15, "returnOnAssets": -0.13854, "returnOnEquity": -0.23562999, "grossProfits": 90847000, "freeCashflow": -26907750, "operatingCashflow": -52797000, "revenueGrowth": 30.434, "grossMargins": 0.80869, "ebitdaMargins": -0.52282, "operatingMargins": -3.0294602, "financialCurrency": "USD", "symbol": "SPRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.414647, "regularMarketPrice": 14.53, "shortName": "ARS Pharmaceuticals, Inc.", "longName": "ARS Pharmaceuticals, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607092200000, "postMarketChangePercent": 0.825877, "postMarketPrice": 14.65, "postMarketChange": 0.12, "regularMarketChange": 0.0599995, "regularMarketDayRange": "14.26 - 14.9146", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1479037, "fiftyTwoWeekLowChange": 4.5299997, "fiftyTwoWeekLowChangePercent": 0.45299998, "fiftyTwoWeekRange": "10.0 - 18.9", "fiftyTwoWeekHighChange": -4.37, "fiftyTwoWeekHighChangePercent": -0.23121692, "fiftyTwoWeekChangePercent": 2.036512, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1762950600, "earningsTimestampEnd": 1762950600, "earningsCallTimestampStart": 1755088200, "earningsCallTimestampEnd": 1755088200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.48, "epsForward": -0.76, "epsCurrentYear": -1.705, "priceEpsCurrentYear": -8.521994, "corporateActions": [], "postMarketTime": 1755300779, "regularMarketTime": 1755288000, "esgPopulated": false, "exchange": "NGM", "messageBoardId": "finmb_585213447", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "fiftyDayAverageChange": -2.2324, "fiftyDayAverageChangePercent": -0.13317902, "twoHundredDayAverageChange": 0.5383501, "twoHundredDayAverageChangePercent": 0.038476527, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Silverback Therapeutics, Inc.", "nameChangeDate": "2025-08-15", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "ARS Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]